Immunobiologic Aspects of Head and Neck Cancer: Clinical and Laboratory Correlates (Q36680648)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1716250%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

review article

1 reference

title

Immunobiologic aspects of head and neck cancer. Clinical and laboratory correlates (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1716250%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

Immunobiologic Aspects of Head and Neck Cancer: Clinical and Laboratory Correlates (English)

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30417-9

6 November 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30417-9

6 November 2022

author name string

Vlock DR

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1716250%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1716250

6 November 2022

publication date

1 August 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1716250%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

17 September 2019

https://api.elsevier.com/content/article/PII:S0889858818304179?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30417-9

https://api.elsevier.com/content/article/PII:S0889858818304179?httpAccept=text/plain

6 November 2022

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30417-9

Hematology / Oncology Clinics of North America

6 November 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1716250%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1716250%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1716250%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

page(s)

797-820

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1716250%20AND%20SRC:MED&resulttype=core&format=json

Factors interfering with immunological rejection of tumours

17 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Mononuclear phagocyte function in head and neck cancer. Chemotactic responsiveness of blood monocytes in correlation between histologic grade of the tumor and infiltration of these cells into the tumor area

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Mucosal immunodeficiency in smokers, and in patients with epithelial head and neck tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Circulating IgA immune complexes in head and neck cancer, nasopharyngeal carcinoma, lung cancer, and colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Immunological skin testing and interpretation. A plea for uniformity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Monocytes and impaired leukocyte migration inhibitory factor production in head and neck squamous carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Immunologic assessment of regional lymph node histology in relation to survival in head and neck carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

The doubtful relevance of nonspecific immune reactivity in patients with squamous cell carcinoma of the head and neck region

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Circulating immune complexes and chemotherapy response in patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Early onset of oral cancer among women who drink and smoke.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

The association of the IGA levels of serum and whole saliva with the progression of oral cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Inhibition of lymphokine-activated killer cell generation by blocking factors in sera of patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Identification and solubilization of iodinated cell surface human melanoma associated antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Antibodies to human squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Treatment of nasopharyngeal carcinoma with human leukocyte interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Effects of protein insufficiency on immune responsiveness.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Adjuvant immuno- and/or chemotherapy with neuraminidase-treated autogenous tumor vaccine and Bacillus Calmette-Guérin for head and neck cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Spontaneous rosette formation and rosette inhibition assays in patients with squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Glomerulopathies of neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Adjuvant chemoimmunotherapy in advanced lesions of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Immunologic abnormalities in head and neck cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Effects of radiation therapy on T-lymphocyte subpopulations in patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

The human lymphokine-activated killer cell system. V. Purified recombinant interleukin 2 activates cytotoxic lymphocytes which lyse both natural killer-resistant autologous and allogeneic tumors and trinitrophenyl-modified autologous peripheral bloo

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Lymphocyte phenotypes at tumor margins in patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Studies on cellular immunity and its serum-mediated inhibition in moloney-virus-induced mouse sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Blocking of cell‐mediated tumor immunity by sera from patients with growing neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Interleukin-2 augments natural killer cell activity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Report on international comparative evaluation of possible value of assays for immune complexes for diagnosis of human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

The role of tobacco and alcohol in the aetiology of lung and larynx cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Immunologic evaluation and prognosis in patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Immunostimulation of patients with head and neck cancer. In vitro and preliminary clinical experiences.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Immunomodulatory activity in regional lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

[Study of head and neck cancer treatment by administration of autologous cytotoxic lymphocyte induced by stimulation with tumor cell--induction of killer cells by stimulation with allogeneic tumor cell]

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Adoptive immunotherapy for head and neck cancer with killer cells induced by stimulation with autologous or allogeneic tumour cells and recombinant interleukin-2

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Circulating levels of immunoglobulin E in patients with cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Lymphocyte response in patients with head and neck cancer: effect of clinical stage and radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

T‐Cell Subpopulations in Head and Neck Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Immunobiologic Staging of Patients with Carcinoma of the Head and Neck

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Major immunoglobulin ratios in carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Primary immunodeficiency diseases and cancer: the immunodeficiency-cancer registry

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Depressed natural killer cell activity in cervical lymph nodes containing focal metastatic squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Study of antibodies against human melanoma produced by somatic cell hybrids

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Escape of tumours from immunological destruction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Serum immunoglobulin E levels in patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Immunocompetence of patients with protein-calorie malnutrition. The effects of nutritional repletion

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

The association of cancer and the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Immunocompetence in Advanced Cancer Patients prior to Chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Delayed hypersensitivity reactions in patients with squamous cell cancer of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

T-lymphocytes and Survival of Head and Neck Squamous Cell Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Cell surface antigens of human ovarian and endometrial carcinoma defined by mouse monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Clinical results of leukocyte interferon-induced tumor regression in resistant human metastatic cancer resistant to chemotherapy and/or radiotherapy-pulse therapy schedule

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Immunomodulatory activity of human leukocyte interferon in cancer patients: results obtained during pulse therapy schedule

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Biochemical characterization of human melanoma cell surfaces: dissection with monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Selective in Vitro Growth of T Lymphocytes from Normal Human Bone Marrows

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Effect of interferon in therapy of skin and head and neck tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Interferons in the treatment of human neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Natural killer cell lysis of head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Circulating immune complexes as an immunological marker in premalignant and malignant lesions of the oral cavity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Immunologic patterns of regional lymph nodes in squamous cell carcinoma of the floor of the mouth. Prognostic significance

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Cancer therapy with interleukin-2: immunologic manipulations can mediate the regression of cancer in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

The C1q Binding Test for Soluble Immune Complexes: Clinical Correlations Obtained in Patients With Cancer 2

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Lymphoid cells in lymph nodes and peripheral blood of patients with squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Correlation of preoperative immunologic test results with recurrence in patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Immunoglobulin complexes in sera of patients with malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Interferon activity and its characterization in the sera of patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Evidence for the role of natural immunity in the control of metastatic spread of head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

The relationship of circulating IgA to cellular immunity in head and neck cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Patterns of recurrence from head and neck cancer. An immunologic perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Immunologic determinants of head and neck cancer response to induction chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

T-lymphocytes as a prognostic indicator in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Cell surface antigens of human malignant melanoma. III. Recognition of autoantibodies with unusual characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Suggestive Evidence That the “Blocking Antibodies” of Tumor-Bearing Individuals May Be Antigen-Antibody Complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

T-cell markers in tumor-infiltrating lymphocytes of head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Sequential chemotherapy and radiotherapy in advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Delayed hypersensitivity in alcoholic cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

T-cell subsets and natural killer cell function with squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Results of BCG adjuvant immunotherapy in 100 patients with epidermoid carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Subclinical immune complexes in the glomeruli of kidneys postmortem

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Ganglioside GM2 as a human tumor antigen (OFA-I-1)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Defective monocyte chemotaxis in patients with head and neck cancer. Restoration after treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Lack of evidence for a role of chemotherapy in the routine management of locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Circulating immune complexes detected by 125I-Clq deviation test in sera of cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Immune complexes, serum proteins, cell-mediated immunity, and immune regulation in patients with squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Prognostic role of antibody reactivity to melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Preliminary trial of nonrecombinant interferon alpha in recurrent squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Serial studies of autologous antibody reactivity to melanoma. Relationship to clinical course and circulating immune complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

A randomized prospective comparison of methotrexate with a combination of methotrexate, bleomycin, and cisplatin in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

T-cell deficiency in patients with squamous cell cancer of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Definite vs adjuvant radiotherapy. Comparative effects on lymphocyte subpopulations in patients with head and neck squamous carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Improvement of impaired leukocyte migration inhibition by thymosin in patients with head and neck squamous carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Alterations in T-lymphocyte subpopulations in patients with head and neck cancer. Correlations with prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Identification of a cell surface protein, p97, in human melanomas and certain other neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Natural killer cell activity in patients with carcinoma of the larynx and hypopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Soluble immune complexes and squamous cell carcinoma-related antigens in patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

Immunologic evaluation of patients with advanced head and neck cancer receiving weekly chemoimmunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930417-9

7 January 2021

The effects of smoking on immunocompetence

20

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30417-9

Lymphocyte subset alterations in nodes regional to human melanoma

6 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30417-9

Tumor-associated antigens in spent medium of human melanoma cells: immunochemical characterization with xenoantisera

6 November 2022

38

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30417-9

Aging, immunity, and malignancy

6 November 2022

39

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30417-9

Cytotoxic responses: the regulatory influence of interleukin-2

6 November 2022

49

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30417-9

Monoclonal antibody (G10) to a common antigen of human squamous cell carcinoma: binding of the antibody to the H type 2 blood group determinant

6 November 2022

67

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30417-9

Augmentation of autologous antibody to human melanoma following acid dissociation and ultrafiltration of serum

6 November 2022

68

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30417-9

The immunologic treatment of cancer

6 November 2022

76

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30417-9

The acute and chronic effects of alcohol on the human immune system

6 November 2022

77

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30417-9

Soluble Immune Complexes in Sera from Head and Neck Cancer Patients: A Preliminary Report

6 November 2022

82

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30417-9

The Quarterly Journal of Medicine

6 November 2022

91

44

523

Ozawa

1975

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30417-9

Alcohol consumption and cellular immunocompetence

6 November 2022

93

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30417-9

Cellular immunity in patients with epidermoid cancer of the head and neck

6 November 2022

94

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30417-9

Preservation of in vitro biological functions in regional lymph node lymphocytes in squamous head and neck cancer

6 November 2022

111

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30417-9

Lymphoid subpopulation changes in regional lymph nodes in squamous head and neck cancer

6 November 2022

112

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30417-9

Natural killer cell activity and head and neck cancer: a clinical assessment

6 November 2022

117

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30417-9

In vitro lymphocyte reactivity and T-cell levels in chronic cigarette smokers

6 November 2022

125

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30417-9

A study of T-lymphocytes and delayed cutaneous hypersensitivity reaction in patients with squamous cell carcinoma of head and neck region

6 November 2022

126

1 reference

https://api.crossref.org/works/10.1016/S0889-8588(18)30417-9

6 November 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1716250%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1 reference